Isotope-Selective Pharmaceutical Composition for Suppressing Degeneration

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current treatments for degenerative diseases, including cancer, primarily focus on symptom management rather than addressing the root causes, and there is a lack of effective curative methods for these progressive conditions.

Innovation Solution

A pharmaceutical composition combining enriched stable isotopes of chemical elements (24Mg, 26Mg, 64Zn, 66Zn, 85Rb, 107Ag, 130Ba, 132Ba, 28Si, 29Si, 32S, 33S, 79Br) and deuterium-depleted water is administered to alter cellular functions and inhibit degenerative processes.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional medications are used to treat degenerative diseases, then symptom management is achieved, but the root cause is not addressed and curative treatment is not possible

Engineering Contradiction:

Improvecurative effectivenessVSAvoidtreatment approach complexity

Core Design Contradiction:

ReliabilityVSDevice complexity

Solution Approach 1:

The patent changes the isotopic parameters of chemical elements (using enriched stable isotopes with altered isotopic ratios) to create a therapeutic composition that addresses the root cause of degenerative diseases. This parameter change in isotopic composition enables curative treatment rather than merely managing symptoms, resolving the contradiction between curative effectiveness and treatment complexity.

Inventive Principle:

Principle #35Parameter changes

2Object-affected harmful factors

If heavy isotopes are present in higher concentrations, then cellular functions are disrupted leading to inflammation and oxidative stress, but the unhealthy metallome imbalance progresses pathology

Engineering Contradiction:

Improvecellular function disruptionVSAvoidhealth outcome

Core Design Contradiction:

Object-affected harmful factorsVSReliability

Solution Approach 1:

Instead of using heavy isotopes that disrupt cellular functions, the patent inverts the approach by using enriched stable isotopes with altered isotopic ratios that restore and optimize cellular functions. This inversion transforms the harmful effect of isotope imbalance into a beneficial therapeutic effect, reducing inflammation and oxidative stress while improving health outcomes.

Inventive Principle:

Principle #13The other way round (Inversion)

3Adaptability or versatility

If a multi-omic approach is used to holistically influence biological processes, then comprehensive influence on protein synthesis and DNA repair is achieved, but the treatment complexity increases

Engineering Contradiction:

Improvebiological process influenceVSAvoidtreatment composition complexity

Core Design Contradiction:

Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The patent creates a composite pharmaceutical composition combining multiple enriched stable isotopes of different chemical elements (magnesium, zinc, rubidium, silver, barium, silicon, sulfur, bromine) with deuterium-depleted water. This composite material approach enables holistic influence on multiple biological processes including protein synthesis, DNA repair, and mitochondrial function, while the synergistic combination reduces the complexity of achieving such comprehensive effects through multiple separate treatments.

Inventive Principle:

Principle #40Composite materials

Data Source

PatentUS12527820B2Pharmaceutical composition and method for suppressing degeneration

Publication Date: 2026.01.20 VECTOR VITALE IP LLC

AI summary

A pharmaceutical composition is used for improving health, curing abnormalities and degenerative diseases, and achieving anti-aging therapeutic effect in mammals. The pharmaceutical composition includes a pharmaceutical carrier and an isotope selective component including at least one of a chemical element in which the isotopic ratio of at least one light isotope is altered to exceed natural abundance.